Latest news
Loading news…
Oncotelic
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Agoura Hills, California, United States Founded 1988 11-50 employees For Profit
Oncotelic is an immuno-oncology company developing RNA therapeutics and small molecule drugs against cancer and infectious diseases.
Oncotelic on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$20.17M
Funding Rounds
3
Last Funding
Acquisitions
3
Monthly Visits
Contacts
12
Ticker
OTLC
OTCQB
Patents
4
About Oncotelic
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- OTLC
- Exchange
- OTCQB
- IPO date
- Mar 30, 2021
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 21
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $1.51K
Company Info
- Founded
- 1988
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 29
- HQ
- Agoura Hills, California, United States
- Region
- Greater Los Angeles Area, West Coast, Western US
- Exit date
- Mar 30, 2021
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- -0.5
- Trend (30d)
- 5.2
- Trend (90d)
- 9.5
Oncotelic Funding Rounds
3 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–3 of 3Show
Page 1 / 1
Oncotelic Acquisitions
3 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| PointR Data | — | 2019-11-04 | Oncotelic | Artificial Intelligence (AI)Information Technology | United States |
| VaxGen | $33M | 2009-10-01 | Oncotelic | Biotechnology | United States |
| Symphony Vida | — | 2009-07-03 | Oncotelic | BiotechnologyOncology | United States |
1–3 of 3Show
Page 1 / 1
Oncotelic Key People
Founder, Chairman and CEO
CMO
Chief Scientific Officer
Chief Clinical Officer for Translational Medicine
CBO/ General Manager of AI Division
12
professional contacts at Oncotelic
Contact execs at Oncotelic →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Oncotelic
People who checked this page also checked these
Sectors Oncotelic invests & acquires in
Browse the full Acquirezy directory.